Maternal and infant outcomes | Pre-Intervention (n = 125) | Post-Intervention (n = 120) | Unadjusted P-Value | Adjusted P-Value* | OR (CI)** |
---|---|---|---|---|---|
Binary outcomes | |||||
Requiring any pharmacotherapy, n (%) | 46 (37%) | 56 (47%) | 0.10 | 0.15 | 1.53 (0.86–2.81) |
Metformin | 20 (16%) | 10 (8.3%) | |||
Insulin | 14 (11%) | 33 (28%) | |||
Metformin + insulin | 12 (10%) | 14 (12%) | |||
Large-for-gestational age, n (%) | 10 (8.0%) | 12 (10.1%) | 0.57 | 0.56 | 1.30 (0.54–3.15) |
Small-for-gestational age, n (%) | 10 (8.0%) | 12 (10.1%) | 0.57 | 0.81 | 1.12 (0.45–2.79) |
Continuous outcomes | |||||
Gestational age for pharmacotherapy, mean (SD), weeks | 30.1 (4.7) | 27.8 (6.8) | 0.05 | ||
Infant birthweight, mean (SD), grams | 3352 (499) | 3290 (470) | 0.32 |